SavedAdd your journal

Journals / Cumhuriyet Science Journal / 2022 / Cilt: 43 - Sayı: 3

Determination of Antiproliferative Effects of Exopolysaccharides from Six Mushroom Species on Glioma Cells

Şerife CAN
Pınar ÖZTOPCU VATAN
Selda KABADERE
Mustafa YAMAÇ
Ruhi UYAR
Pages
365–369
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies are needed to understand these effects more clearly on glioma.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Glial tumors are the largest and danger group of central nervous system tumors.
📊
Key Findings & Data:In this study the effects of 0.4, 1, 2, 4 and 6 μg/mL doses of EPSs from six mushroom species Coprinus comatus, Fistulina hepatica, Panus neostrigosus, Laetiporus sulphureus, Polyporus squamosus, and Lenzites betulinus were investigated on the rat glioma cell line (C6) in two different periods by MTT assay.
💡
Conclusion & Impact:Further studies are needed to understand these effects more clearly on glioma.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Glial tumors are the largest and danger group of central nervous system tumors. The use of natural products now has been contemplated of exceptional value in the control of cancer. Mushrooms have been used for many centuries, not just as a food, but also to treat many illnesses. Therefore, we aimed to evaluate the effect of exopolysaccharides (EPS) obtained from six different edible mushrooms on the survival of glioma cells. In this study the effects of 0.4, 1, 2, 4 and 6 μg/mL doses of EPSs from six mushroom species Coprinus comatus, Fistulina hepatica, Panus neostrigosus, Laetiporus sulphureus, Polyporus squamosus, and Lenzites betulinus were investigated on the rat glioma cell line (C6) in two different periods by MTT assay. According to our results 0.4 and 1 μg/mL of EPSs from six mushroom species were not effective or less effective, but 2, 4 and 6 μg/mL doses killed glioma cells about 27 to 71 % for 24 hours, 35 to 78 % for 48 hours As a result, these mushroom EPSs showed different cytotoxicity to glioma cells time and dose-dependently. These findings can be suggested that the anti-tumor effects of EPSs can be potential use in clinical applications to treat glioma. Further studies are needed to understand these effects more clearly on glioma.

🔖

Cite This Article

CAN, Ş., VATAN, P. Ö., KABADERE, S., YAMAÇ, M., UYAR, R. (2022). Determination of Antiproliferative Effects of Exopolysaccharides from Six Mushroom Species on Glioma Cells. Cumhuriyet Science Journal, Cilt: 43 - Sayı: 3, 365–369. https://ajindex.com/articles/649440

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Barillot E., Calzone L., Hupe P., Vert J.P., Zinovyev A., Computation system biology of cancer, USA: CRC Press, Taylor and Francis Group. A Chapman and Hall Book, (2013)
  2. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J., Cancer statistics CA, A Cancer Journal for Clinicians, 59(4) (2009) 225-49
  3. Zjawiony J.K., Biologically active compounds from Aphyllophorales (Polypore) Fungi, Journal of Natural Products, 67(2) (2004) 300-310
  4. Wasser S.P., Medicinal mushroom science: Current Perspectives, Advances, Evidences, and Challenges, Biomedical Journal, 37(6) (2014) 345-356
  5. Savelkoul H.F.J., Chanput W., Wichers H.J., Immunomodulatory effects of mushroom β-glucans. In: Diet, Immunity and Inflammation, (Eds. PC Calder and P Yaqoob): 416–434. Woodhead Publishing Series in Food Science, Technology and Nutrition, (2013)
  6. Sanchez C., Bioactives from Mushroom and Their Application. In: Food Bioactives, (Ed M Puri): 23–57. Springer International Publishing, (2007)
  7. Khan A.A., Gani A., Khanday F.A., Masoodi F.A., Biological and pharmaceutical activities of mushroom β-glucan discussed as a potential functional food ingredient, Bioactive Carbohydrates and Dietary Fibre, 16 (2018) 1–13
  8. Chaturvedi V.K., Agarwal S., Gupta K.K., Ramteke P.W., Singh M.P., Medicinal mushroom: boon for therapeutic applications, 3 Biotech, 8 (2018) 334
  9. Wasser S.P., Medicinal mushrooms as a source of antitumor and immunomodulation Polysaccharides, Applied Microbiology and Biotechnology, 60 (2002) 258–274
  10. Wasser S.P., Medicinal mushrooms in human clinical studies. Part I. Anticancer, oncoimmunological, and immunomodulatory activities: A review, International Journal of Medicinal Mushrooms, 19 (2017) 279–317
  11. Vitak T., Yurkiv B., Wasser S., Nevo E., Sybirna N., Effect of medicinal mushrooms on blood cells under conditions of diabetes mellitus, World Journal of Diabetes, 8(5) (2017) 187–201
  12. Dudekula U.T., Doriya K., Devarai S.K., A critical review on submerged production of mushroom and their bioactive metabolites, 3 Biotech, 10 (2020) 337
  13. Nowakowski P., Markiewicz Z.R., Gromkowska-Kępka K, Naliwajko S.K., Moskwa J., Bielecka J., Grabia M., Borawska M., Socha K., Mushrooms as potential therapeutic agents in the treatment of cancer: Evaluation of anti-glioma effects of Coprinus comatus, Cantharellus cibarius, Lycoperdon perlatum and Lactarius deliciosus extracts, Biomedicine & Pharmacotherapy, 133 (2021) 111094
  14. Zhang M., Cui S.W.,